Weekly report notes 92 active COVID-19 cases, 4 new deaths
The Amarillo Public Health Department (APHD) reported an increase of 27 new COVID-19 cases and four new deaths over the past week in its weekly COVID-19 report card released Friday.
The report is posted every Friday with updated data from BSA Health System, Northwest Texas Healthcare System, and Thomas E. Creek VA Medical Center.
Trauma Service Area A, which includes Potter and Randall counties as well as the majority of the Texas Panhandle, is recording a .75% COVID-19 hospitalization rate as of Thursday, according to the State Department of Health Services website.
The weekly COVID-19 report, issued Fridays by the Amarillo Public Health Department.
The 27 new COVID-19 active cases amount to a seven-day, new-case average of four, with a seven-day positivity rate of 1%, according to the report card.
That brings the total number of cases in Potter and Randall counties to 74,155 and the total number of deaths to 1,224 since the beginning of the pandemic in March 2020.
Full numbers can be found on the APHD website.
A total of 92 cases were considered active on the website Friday.
According to the site, there have been 72,839 total recoveries for the area.
Potter County's total cases rose to 35,806 since the start of the pandemic. Of the total, 44 are active, with 35,037 recoveries and 725 deaths related to the virus, according to the APHD website.
Randall County's total COVID-19 cases rose to 38,349 since the start of the pandemic. Of the total, 48 are active, with 37,802 recoveries and 499 deaths related to the virus.
According to the APHD website, 579,197 COVID-19 tests have been conducted since the start of the pandemic.
By the Centers for Disease Control standards, both Randall and Potter counties' community levels of COVID-19 were considered Low, or Green, as of Thursday.
The Amarillo Public Health COVID-19 Hospitalization report, also being released each Friday, noted five COVID-19 patients hospitalized, 60% of whom are not vaccinated, with one patient in the ICU and none on ventilators. The ICU patient is not vaccinated.
Story continues
For more information on COVID-19 and the vaccine, visit amarilloalerts.com
Editor's note: Some of the numbers surrounding COVID-19 cases listed in this story are different on the weekly report card, vs. the APHD website. According to the public health department, readers can check the website for the latest updates and totals.
This article originally appeared on Amarillo Globe-News: Weekly Amarillo report notes 92 active COVID-19 cases, 4 new deaths
02
Azelis: Weekly Report on LTIP Implementation Program
Azelis reports on progress of LTIP implementation program
ANTWERP, Belgium, April 15, 2022--(BUSINESS WIRE)--Regulatory News:
Further to the launch of the Long-term Incentive Plan (LTIP) announced on 16 March 2022, the Group reports the purchase of 13,000 ordinary shares of Azelis (Brussels: AZE) in the period from 8 April 2022 until 14 April 2022.
Date
Number of shares
Total amount (EUR)
Average price (EUR)
Lowest price (EUR)
Highest price (EUR)
Trading venue
8 April 2022
3,000
66,983.40
22.3278
21.8800
22.6400
Euronext Brussels
11 April 2022
5,000
112,066.50
22.4133
22.1200
22.5000
Euronext Brussels
12 April 2022
1,500
34,446.60
22.9644
22.2600
23.2800
Euronext Brussels
13 April 2022
2,000
46,750.00
23.3750
22.9200
23.8000
Euronext Brussels
14 April 2022
1,500
35,829.00
23.8860
23.7000
24.000
Euronext Brussels
Total
13,000
296,075.50
22.7750
Since the start of the implementation of the buy-back program on 17 March 2022, Azelis has bought back 77,900 shares for a total amount of EUR 1,698,537.38. This corresponds to 0.033 % of the total shares outstanding. The purpose of this program is to cover future obligations for share awards under Azelis' LTIP.
An overview of the share buy-back program is available on the investor relations pages of Azelis' website under the section "Regulated Information".
About Azelis
Azelis is a leading global innovation service provider in the specialty chemical and food ingredients industry present in 57 countries across the globe with +3,000 employees. Our knowledgeable teams of industry, market and technical experts are each dedicated to a specific market within Life Sciences and Industrial Chemicals. We offer a lateral value chain of complementary products to more than 51,000 customers, supported by ~2,300 principal relationships, creating a turnover of €2.8 billion. Azelis Group NV is listed on Euronext Brussels under ticker AZE.
Across our extensive network of more than 60 application laboratories, our award-winning staff help develop formulations and provide technical guidance throughout the customers’ product development process. We combine a global market reach with a local footprint to offer a reliable, integrated and unique digital service to local customers and attractive business opportunities to principals. EcoVadis Platinum rated, Azelis is a leader in sustainability. We believe in building and nurturing solid, honest and transparent relationships with our people and partners.
Story continues
Impact through ideas. Innovation through formulation.
www.azelis.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20220414005851/en/
Contacts
AzelisMeredith WoodCorporate Communications Business PartnerT: +32 485 293 665E: [email protected]
03
Weekly COVID report: three more deaths, seven more cases in a week
The Tuscarawas County Health Department reported there were 76 active cases of COVID-19 as of Thursday, which was eight fewer cases than in the previous seven-day reporting period.
Tuscarawas County had seven new COVID-19 cases reported between 2 p.m. on March 31 and 2 p.m. Thursday. There were four new hospitalizations of county residents and three more deaths.
As of Friday, 496 Tuscarawas County residents had been lost to COVID-19 related deaths, according to the health department.
Cleveland Clinic Union Hospital in Dover reported having two inpatients with a confirmed diagnosis of COVID-19 on Friday. Neither is in intensive care. On April 1, there were no inpatients with COVID-19 being treated at Union Hospital.
The majority of severe COVID-19 cases in Ohio continue to be among those who are not fully vaccinated, according to the health department.
Upcoming vaccine clinics are scheduled for April 21 from 8 a.m. to 10 a.m. at the Claymont Senior Center, 633 N. Main St., Uhrichsville; and April 22 from 9 a.m. to 10:30 a.m. at the Garaway Senior Center, 221 Dover Road, Sugarcreek.
The county health department is offering COVID-19 vaccines and booster shots. Appointments may be made by calling 330-343-5555, extension 174 or 181 Monday through Friday between 8 a.m. and 4 p.m.
This article originally appeared on The Times-Reporter: Tuscarawas County sees 7 new COVID cases, 3 COVID deaths in a week